Patient guide · High cholesterol
Cholesterol: what good care looks like
LDL cholesterol causes heart attacks and strokes, and lowering it with proven medicines prevents them. Here is what the guidelines recommend and how to know your care follows them.
What high cholesterol is, in plain language
Cholesterol is a fatty substance your body needs to build cells and hormones, carried through the blood by particles called lipoproteins. LDL ("bad" cholesterol) deposits cholesterol into artery walls, where it builds up as plaque over years; HDL ("good" cholesterol) helps carry cholesterol away. Triglycerides are a different type of blood fat, and very high levels raise the risk of pancreatitis.
High LDL usually causes no symptoms. The danger is silent: plaque narrows and stiffens arteries, and a plaque can rupture suddenly and trigger a heart attack or stroke. Lowering LDL, especially over many years, reduces that risk substantially, which is why cholesterol is treated even though it does not make you feel sick.
What the current guidelines recommend
The main guideline is the 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia (March 2026), which replaced the 2018 cholesterol guideline. Key points: LDL goals of under 55, 70, or 100 mg/dL by risk; the PREVENT risk calculator; Lp(a) measured once in a lifetime; calcium scoring for borderline risk; ezetimibe, bempedoic acid, or a PCSK9 inhibitor added sooner when a statin alone is not enough; no supplements or fish oil pills for cholesterol.
The treatments, and why each one is recommended
Statins (atorvastatin, rosuvastatin, and others) are the foundation of treatment for almost everyone who needs medicine. They lower LDL by 30 to 55 percent depending on the dose, and decades of trials show they reduce heart attacks, strokes, and cardiovascular death. Muscle aches are the most talked-about side effect, but true statin intolerance is uncommon, and a different statin or dose can usually be found.
Ezetimibe is added when a statin alone does not reach the LDL goal; it blocks cholesterol absorption in the gut and adds another 15 to 20 percent LDL lowering with minimal side effects.
PCSK9 inhibitors (alirocumab, evolocumab), given as an injection every two to four weeks, and inclisiran, given twice a year, lower LDL by 50 percent or more and are used for people at very high risk who are not at goal on oral therapy, or who cannot tolerate a statin.
Bempedoic acid is an oral, non-statin option for people who cannot tolerate statins, lowering LDL by about 15 to 25 percent.
For high triglycerides, icosapent ethyl (a purified, prescription fish oil, not an over-the-counter supplement) has been shown to reduce cardiovascular events in people with elevated triglycerides who are already on a statin.
What guideline-based care looks like at a visit
A good clinician orders a lipid panel, calculates your 10-year cardiovascular risk (the guideline now uses the AHA PREVENT calculator), and sets an LDL goal based on that risk rather than treating a single number the same way for everyone. Lipoprotein(a), or Lp(a), should be checked at least once in your life, since a high level raises risk independent of LDL and does not change much over time. A coronary artery calcium scan may be offered when your risk level is borderline, to help decide how aggressively to treat.
After starting or changing a medicine, expect a follow-up lipid panel in 4 to 12 weeks to check whether you are at goal, then rechecks every 3 to 12 months once stable.
Red flags that a clinician is not following the guidelines
- Selling supplements, peptides, or compounded drugs as treatment
- Stopping proven medicines without a medical reason
- Ordering unproven tests or “detox” programs
- Telling you the guidelines are wrong without evidence
- Recommending fish oil supplements, niacin, or other over-the-counter products in place of a statin or other proven prescription therapy
Why choosing a guideline-based clinician matters
Large trial meta-analyses show that for every 39 mg/dL reduction in LDL cholesterol, the risk of a major cardiovascular event (heart attack, stroke, or cardiovascular death) drops by roughly a quarter, and the benefit grows the longer treatment continues. Statins remain the best-studied and most effective tool for this, which is why a clinician who avoids proven medicine in favor of supplements or unproven "cleanses" is working against evidence that has been confirmed in millions of patients.
Questions to ask your doctor
- Which guideline do you follow for high cholesterol, and what year is it from?
- Which of the recommended treatments am I on, and if not, why not?
- What targets are we aiming for, and how will we track them?
- What should make me call you before my next visit?
- Do you sell any supplements or compounded medicines? (A guideline-based clinic does not.)
Find a vetted lipidologist near you
Every lipidologist on DoctorDirectory.ai is license-verified, board-certified, and has signed a dated attestation to these guidelines. No patient reviews or star ratings, just facts you can check.
The guidelines behind this guide
Summaries in plain language, with links to the official documents and PDFs.
ACC / AHA and 9 partner societies (incl. NLA, ASPC, ADA) · 2026
Replaces the 2018 cholesterol guideline (published March 13, 2026)2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia
- Number goals are back: LDL under 55, 70, or 100 mg/dL depending on your risk, with matching non-HDL goals of under 85, 100, or 130.
- Risk is now estimated with the AHA PREVENT calculator, which gives 10-year and 30-year risk, does not use race, and includes kidney function.
- Everyone should have lipoprotein(a) measured once in adulthood; a high level raises risk even when LDL looks fine.
- A coronary calcium scan is now a strong recommendation for men over 40 and women over 45 with borderline or intermediate risk; any calcium supports an LDL goal under 100.
- If a statin alone does not reach the goal, add ezetimibe, bempedoic acid, or a PCSK9 inhibitor sooner rather than waiting. Inclisiran is an option mainly for people with heart disease who cannot use the other injectables.
- Reported statin muscle symptoms usually have another cause: try a different statin or dose and combine with non-statin pills rather than stopping treatment.
- Cholesterol care starts earlier: a cholesterol check for children ages 9 to 11, and medicine considered for young adults with LDL 160 or higher or a strong family history.
- Over-the-counter supplements and fish oil pills are not recommended for lowering cholesterol. Prescription icosapent ethyl or fenofibrate may be considered for high triglycerides.
- Pregnancy history now counts toward risk (preeclampsia, gestational diabetes, early menopause, PCOS), with dedicated guidance for older adults, kidney disease, and HIV.
National Lipid Association · 2024
NLA Scientific Statement on Lipoprotein(a): Use in Clinical Practice (2024 focused update)
- Everyone should have lipoprotein(a), or Lp(a), measured at least once in their life. It is inherited and does not change much.
- A high Lp(a) raises heart attack, stroke, and aortic valve risk on its own, so it moves people into a higher-risk group.
- Until Lp(a)-lowering drugs finish trials, the treatment is tighter control of everything else, especially LDL and blood pressure.
Read the guidelinedoi:10.1016/j.jacl.2024.03.001American College of Cardiology · 2022
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering
- Explains when to add medicines beyond a statin: ezetimibe, PCSK9 antibodies, inclisiran, and bempedoic acid.
- Sets LDL goals for the highest-risk patients (below 55 or below 70 depending on risk) and says to act when a goal is missed.
- Gives a plan for people who cannot tolerate statins rather than leaving them untreated.
Read the guidelinedoi:10.1016/j.jacc.2022.07.006US Preventive Services Task Force · 2022
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: USPSTF Recommendation Statement
- Adults 40 to 75 with at least one risk factor and a 10-year risk of 10 percent or more should be offered a statin.
- Those with 7.5 to 10 percent risk may benefit; it is a shared decision.
- The evidence review found statins lower deaths, heart attacks, and strokes with no increase in serious harms.
Read the guidelinedoi:10.1001/jama.2022.13044AHA / ACC and 10 partner societies · 2018
Superseded by the 2026 dyslipidemia guideline; kept for reference2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol
- A heart-healthy lifestyle is the base for everyone, at every age.
- People who already have heart disease, very high LDL (190 or more), or diabetes should be on a statin. For others, a 10-year risk score plus a conversation decides.
- If LDL stays high on the strongest statin dose you tolerate, ezetimibe and then a PCSK9 inhibitor are added for the highest-risk patients.
- A coronary calcium scan can settle the question when the decision is unclear.
- LDL should be rechecked 4 to 12 weeks after any change, then every 3 to 12 months.
Find a vetted lipidologist near you
Every lipidologist listed has a verified license, board certifications on record, and a dated attestation to these guidelines. No reviews, no ratings.
Dr. Mohammed Alo, DO
VerifiedCardiologist, Preventive cardiologist · Toledo, OH
Board-certified cardiologist and internist in northwest Ohio who focuses on preventive cardiology, weight loss and lipidology, and is an Assistant Clinical Professor of Medicine at Ohio University.
Call (419) 567-1999Dr. Michael Richman, MD
VerifiedLipidologist, Cardiothoracic surgeon · Los Angeles, CA
Los Angeles physician who trained as a cardiothoracic and general surgeon before founding The Center for Cholesterol Management, now focused on preventive cardiology and cholesterol management, board-certified in both general and thoracic surgery.
Call (310) 481-3939Lipidologist, Weight loss doctor · Holland, MI
Triple board-certified in family medicine, obesity medicine, and lipidology, based in Holland, Michigan, treating obesity and cardiometabolic disease by telemedicine nationwide through Vineyard, and known as the Doc Who Lifts for putting exercise and evidence first.
Call (415) 625-1768

